P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

May 2004

Features

Health Care and Law

The New Federal Fetal Protection Law: Implications for Health Policy

The author discusses the potential ramifications of a new law that considers it to be a crime to terminate the life of a fetus when certain acts of violence are committed against a pregnant woman.
Robert I. Field, JD, MPH, PhD

Measuring Clinical Effectiveness Using Common Hospital Data

The authors discuss the Clinical Effectiveness Initiative, which is designed to aid P&T committee members and managers of health care institutions in balancing hospital pharmacy costs and providing optimal patient outcomes.
Leo K. Lichtig, PhD, Richard M. Weinberg, MD, Robert A. Knauf, MPH, and F. Randy Vogenberg, RPh, PhD

Meeting Highlights

Highlights of the 53rd Scientific Session of The American College of Cardiology

Dr. Prescott reviews therapies for acute coronary syndrome, angina pectoris, dyslipidemia, and heart failure, among others, using statins, vasodilators, thrombin inhibitors, beta blockers, and recombinant B-type natriuretic peptide.
Lawrence M. Prescott, PhD

Meeting Highlights

Lymphoma Workshop: Understanding Lymphoma — Current and Future Treatment Options

Some promising therapies were discussed at a recent meeting of the Lymphoma Foundation and the Cancer Institute of New Jersey.
Marvin M. Goldenberg, PhD, RPh, MS

Therapeutic Monitoring of Theophylline in Newborns with Apnea

Accurate monitoring of theophylline in apneic infants is essential in order to ensure therapeutic levels and to avoid prolonged hospital stays.
Hugo Juárez-Olguín, MSc, Janett Flores-Pérez, MSc, Gabriela Pérez-Guillé, MD, Adrián Guillé-Pérez, MSc, Angélica Camacho-Vieyra, MD, Carmen Flores-Pérez, MSc, and Mayra Jarillo-Alvarado, MSc

Departments

Editorial

Outpatient Drug Safety: The Final Frontier

David Nash, MD, MBA, discusses the often overlooked need for improved drug safety for ambulatory patients.
David Nash, MD, MBA

Letter to P&T

A reader expresses concern about a possible relationship between his arthritis medication and heart failure.

Medication Errors

Adverse Drug Reactions: Documentation Is Important, but Communication Is Critical

Matthew Grissinger, RPh, FASCP, explains how communication among health care providers, pharmacists, and patients is vital in preventing adverse drug reactions.
Matthew Grissinger, RPh, FASCP

New Drugs/Drug News/ New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Prescription: Washington

FDA on the Defensive: Do Antidepressants Harm Children?

Stephen Barlas discusses the ongoing debate about the safety of the newer atypical antidepressants in children.
Stephen Barlas

Drug Forecast

Tadalafil in the Treatment of Erectile Dysfunction

The authors review tadalafil (Cialis™) for the treatment of erectile dysfunction.
Tarrah Williams, PharmD Candidate, Marlon Honeywell, PharmD, Evans Branch III, PharmD, Patty Ghazvini, PharmD, and Keisha King, PharmD